These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30088269)

  • 21. Ambulatory surgery and malignant hyperthermia.
    Brandom BW
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Implications for malignant hyperthermia treatment.
    Reber A; Schumacher P; Urwyler A
    Anaesthesia; 1993 Oct; 48(10):862-5. PubMed ID: 8238827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Optiflow™ nasal high-flow oxygen in a patient with malignant hyperthermia.
    Coulter S; Girgis M
    Br J Anaesth; 2018 Sep; 121(3):680. PubMed ID: 30115272
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Emmanuel ER
    Anaesthesia; 1988 Aug; 43(8):666-70. PubMed ID: 3421459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An effective way to disseminate protocols for managing malignant hyperthermia.
    Watson CB; Norfleet EA
    Anesthesiology; 1984 May; 60(5):510-1. PubMed ID: 6711866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Malignant hyperthermia - problem in dental surgery. An introductory report].
    Kamińska E; Janas A; Osica P
    Dev Period Med; 2014; 18(4):483-8. PubMed ID: 25874788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a formal statistical analysis always necessary?
    Woehlck H
    Anesth Analg; 2011 Jun; 112(6):1268-9. PubMed ID: 21613193
    [No Abstract]   [Full Text] [Related]  

  • 29. Xenon anaesthesia in a patient with susceptibility to malignant hyperthermia: A case report.
    Carlomagno M; Esposito C; Marra A; Vargas M; Corcione A
    Eur J Anaesthesiol; 2016 Feb; 33(2):147-50. PubMed ID: 26164252
    [No Abstract]   [Full Text] [Related]  

  • 30. Anesthesia case of the month. Malignant hyperthermia.
    Chohan AS; Greene SA
    J Am Vet Med Assoc; 2011 Oct; 239(7):936-40. PubMed ID: 21961631
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of malignant hyperthermia in Denmark.
    Ording H
    Anesth Analg; 1985 Jul; 64(7):700-4. PubMed ID: 4014731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia: turn down the heat.
    Mitchell-Brown F
    Nursing; 2012 May; 42(5):38-44; quiz 44-5. PubMed ID: 22488207
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant hyperthermia: an OR emergency!
    Plast Surg Nurs; 2000; 20(4):222-6. PubMed ID: 12025057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eltanolone (5-beta-pregnanolone) does not trigger, and attenuates halothane triggering of, malignant hyperthermia in malignant hyperthermia susceptible swine.
    Harrison GG; Dyer RA; Llewellyn RL; James MF
    Pharmacol Res; 1999 Feb; 39(2):103-6. PubMed ID: 10072700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of neuroleptoanesthesia for carrying out a Harrington intervention in a patient probably susceptible to malignant hyperthermia].
    Lauri A; Corbari M; Galli C; Marri M
    Minerva Anestesiol; 1989 Sep; 55(9):331-5. PubMed ID: 2633080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of cognitive aid checklist leading to successful treatment of malignant hyperthermia in an infant undergoing cranioplasty.
    Ranganathan P; Phillips JH; Attaallah AF; Vallejo MC
    Anesth Analg; 2014 Jun; 118(6):1387. PubMed ID: 24842184
    [No Abstract]   [Full Text] [Related]  

  • 37. A talisman to ward off the bad anaesthetics.
    Mearns CA
    Anaesthesia; 2002 Sep; 57(9):943. PubMed ID: 12240620
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malignant hyperthermia: clinical aspects and treatment (author's transl)].
    Freitag B
    Zentralbl Chir; 1979; 104(6):353-8. PubMed ID: 452750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Charcoal and isoflurane alveolar washout in low-flow circuit].
    Romano E; Pegoraro M; Vacri A; Pecchiari C; Auci E
    Minerva Anestesiol; 1993 May; 59(5):223-7. PubMed ID: 8355862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.